Larvol Delta - Moleculin-Receives-FDA-Orphan-Drug-Designation-of-WP1122-for-the-Treatment-of-Glioblastoma-Multiforme

WP1122 - Moleculin, CNS Pharma, WPD Pharma

https://www.prnewswire.com/news-releases/moleculin-receives-fda-orphan-drug-designation-of-wp1122-for-the-treatment-of-glioblastoma-multiforme-301617845.html

Sep 6, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next